DOCN vs PATH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

DOCN

41.6
AI Score
VS
PATH Wins

PATH

51.9
AI Score

Investment Advisor Scores

DOCN

42score
Recommendation
HOLD

PATH

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DOCN PATH Winner
Revenue 539.09M 828.64M PATH
Net Income 51.21M 58.61M PATH
Gross Margin 55.5% 81.0% PATH
Net Margin 9.5% 7.1% DOCN
Operating Income 65.94M 59.59M DOCN
ROE 5.5% 3.0% DOCN
ROA 1.6% 2.0% PATH
Total Assets 3.12B 2.91B DOCN
Cash 767.03M 607.41M DOCN
Current Ratio 1.31 2.39 PATH
Free Cash Flow 75.31M 158.55M PATH

Relative Price Performance (Last 90 Days)

DOCN 1M: +28.4% · 3M: +7.4% PATH 1M: -26.6% · 3M: +13.7%

Current Technical Phase

DOCN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.9 · Price: $139.80

PATH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.0 · Price: $13.32

Fundamentals Snapshot

Metric DOCN PATH
Market Cap — —
Forward P/E 75.9 17.5
Trailing P/E 60.6 18.3
Revenue (TTM) — —
Revenue Growth 0.3% 0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.1%
EPS 2.20 0.70
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PATH is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.